1. Infliximab [Remicade]: warning information added to US label

   Meeting report 21 January 2013 Pages: 2 - 2

2. Medication errors: identifying causes and finding solutions

   News item 21 January 2013 Pages: 2 - 2

3. Epirubicin + paclitaxel: no increase in cardiotoxicity

   Clinical study 21 January 2013 Pages: 3 - 3

4. Increased epirubicin dose tolerable in adjuvant FEC therapy

   Clinical study 21 January 2013 Pages: 3 - 3

5. Long-term simvastatin treatment not associated with cancer risk

   Incidence study 21 January 2013 Pages: 3 - 3

6. Oral glucocorticoid use a risk factor for heart failure?

   News item 21 January 2013 Pages: 3 - 3

7. Antidepressant-associated manic conversion risk age-related

   Clinical study 21 January 2013 Pages: 4 - 4

8. Decline in use slow after safety warnings for cisapride, troglitazone

   Clinical study 21 January 2013 Pages: 4 - 4

9. Gemcitabine associated with decreased diffusion capacity

   Clinical study 21 January 2013 Pages: 4 - 4

10. Tramadol/warfarin interaction related to CYP2D6 activity

    Clinical study 21 January 2013 Pages: 4 - 4

11. Glucocorticoids may not reduce BMD in children and adolescents

    News item 21 January 2013 Pages: 5 - 5

12. HRT: elevated risk of all breast cancer prognostic types?

    Clinical study 21 January 2013 Pages: 5 - 5

13. Levacecarnine improves antiretroviral-induced neuropathy

    Clinical study 21 January 2013 Pages: 5 - 5

14. Lidocaine/prilocaine reduces depot antipsychotic injection-site pain

    Clinical study 21 January 2013 Pages: 5 - 5

15. Alendronic acid

    Case report 21 January 2013 Pages: 6 - 6

16. Anthrax vaccine

    Case reports 21 January 2013 Pages: 6 - 6

17. Antivenins

    Case report 21 January 2013 Pages: 6 - 6

18. Benzyl alcohol

    Case report 21 January 2013 Pages: 6 - 7

19. Cabergoline/pergolide

    Case reports 21 January 2013 Pages: 7 - 7

20. Capecitabine

    Case report 21 January 2013 Pages: 7 - 7

21. Carbamazepine

    Case report 21 January 2013 Pages: 7 - 8

22. Carbamazepine interaction

    Case report 21 January 2013 Pages: 8 - 8

23. Celecoxib

    Case report 21 January 2013 Pages: 8 - 8

24. Celecoxib interaction

    Case report 21 January 2013 Pages: 8 - 8

25. Chloroquine

    Case report 21 January 2013 Pages: 8 - 8

26. Dalteparin sodium

    Case report 21 January 2013 Pages: 9 - 9

27. Digoxin interaction

    Case report 21 January 2013 Pages: 9 - 9

28. Doxifluridine

    Case report 21 January 2013 Pages: 9 - 9

29. Efavirenz/lamivudine/zidovudine

    Case report 21 January 2013 Pages: 9 - 9

30. Estradiol

    Case report 21 January 2013 Pages: 10 - 10

31. Fludarabine

    Case report 21 January 2013 Pages: 10 - 10

32. Flutamide

    Case report 21 January 2013 Pages: 10 - 10

33. Indinavir

    Case report 21 January 2013 Pages: 10 - 10

34. Irinotecan

    Case report 21 January 2013 Pages: 11 - 11

35. Leuprorelin withdrawal

    Case report 21 January 2013 Pages: 11 - 11

36. Levofloxacin

    Case report 21 January 2013 Pages: 11 - 11

37. Lithium

    Case report 21 January 2013 Pages: 11 - 11

38. Lithium

    Correspondence 21 January 2013 Pages: 12 - 12

39. Mirtazapine

    Case report 21 January 2013 Pages: 12 - 12

40. Mirtazapine

    Case report 21 January 2013 Pages: 12 - 12

41. Olanzapine

    Case report 21 January 2013 Pages: 12 - 13

42. Olanzapine

    Case report 21 January 2013 Pages: 13 - 13

43. Poliomyelitis vaccine inactivated

    Case report 21 January 2013 Pages: 13 - 13

44. Sotalol

    Case report 21 January 2013 Pages: 13 - 13

45. Sulphan blue

    Case report 21 January 2013 Pages: 13 - 13

46. Tacrolimus

    Case report 21 January 2013 Pages: 14 - 14

47. Tetracycline

    Case report 21 January 2013 Pages: 14 - 14

48. Trofosfamide

    Case report 21 January 2013 Pages: 14 - 14

49. Verapamil

    Case report 21 January 2013 Pages: 14 - 15